Nuzenio

Sustained Efficacy Over

Sustained Efficacy Over entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Deucravacitinib Shows Sustained Efficacy and Safety Over Placebo in Active Psoriatic Arthritis - MedscapeMedscape · Thu, 06 Aug 2026 12:26:24 GMT Risankizumab Shows Superior and Sustained Efficacy Over Ixekizumab in Moderate-to-Severe Psoriasis: Study - Medical DialoguesMedical Dialogues · Tue, 28 Jul 2026 14:30:16 GMT

Timeline

Thu, 06 Aug 2026 12:26:24 GMTDeucravacitinib Shows Sustained Efficacy and Safety Over Placebo in Active Psoriatic Arthritis - Medscape

Tue, 28 Jul 2026 14:30:16 GMTRisankizumab Shows Superior and Sustained Efficacy Over Ixekizumab in Moderate-to-Severe Psoriasis: Study - Medical Dialogues

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Safety Over Placebo2 live mentions Active Psoriatic Arthritis2 live mentions Ixekizumab2 live mentions Moderate2 live mentions Severe Psoriasis2 live mentions Deucravacitinib Shows Sustained1 live mentions Efficacy1 live mentions Medscape Deucravacitinib Shows1 live mentions Sustained Efficacy1 live mentions Medscape Medscape1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sustained Efficacy Over.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.